A new study is coming soon for Post-menopausal Females and Sterilised Females via Bilateral Oophorectomy. Please read the following information carefully. If you are potentially interested in the trial, please respond to this email or call the Covance Clinical Research Recruitment Team between 09.00am – 19.00pm on 0113 3945200 or on 0800 591570
If you meet the following criteria, you may be eligible for this trial:
- Post-menopausal females or females sterilised via bilateral oophorectomy.
- Aged between 45 – 70.
- BMI between 18 – 32.
- Non-smokers or smokers of up to 10 daily.
- HRT is NOT acceptable.
- Your second screening payment will be £250.
- Study payment is £2480 plus travel.
Please note that more restrictions may become applicable once recruitment for the study begins. Once you have registered your interest, we will provide you with more information as it becomes available.
You will be required to attend potentially two medical screenings. Should you pass your first screening, you will be invited to a second screening, where you will be required to have a vaginal ultrasound, a cervical smear, and a breast and genital examination. These examinations will be conducted by a gynecology specialist. Please read the following information carefully.
During the screening for this study, you will be required to visit a gynecology specialist doctor who will do a gynecological examination followed by a cervical smear test and a transvaginal scan.
The gynecological examination consists of examination of your breasts and your genital area externally and internally. This will include examination of the vulva, vagina and cervix. For this examination, the doctor will have to insert a metal speculum into your vagina, as if you were having a smear . Your vulva, vagina and cervix will be examined carefully. The speculum is then removed and an internal pelvic examination is performed. This allows the doctor to gauge the size, shape and consistency of your womb, and also assess if there is any tenderness in your pelvis.
During the physical examination, the doctor will also do a cervical smear test. Cervical screening is not a test for cancer; it is a test to check the health of the cells of the cervix. The cervical screening test usually takes around five minutes to carry out. An instrument called a speculum will be gently inserted into your vagina to hold the walls of your vagina open so that your cervix is visible. A small brush-like instrument will be used to take some cells from the surface of your cervix.
The gynecological examination and cervical smear test is followed by a vaginal ultrasound scan.
A vaginal ultrasound is performed by gently inserting a scan probe into your vagina, which you may find slightly uncomfortable. It takes about 10 minutes. It uses high frequency sound waves to create an image of the inside of your vagina, womb and ovaries. This helps us visualise your womb and ovaries clearly in order to assess the health of your womb and ovaries.
All the tests described above will enable us to assess your gynaecological health and assess the eligibility for your participation in the clinical trial.
Proposed Study Dates
- Check-in – 17th Jul7 2013
- Check-out – 31st July 2013
- Out-patient Visit – 4th, 5th, 6th, 7th August 2013 (if required)
The study payment of £2480 is based on one 14 night stay. Should it be deemed necessary, this may be extended for a further 3 days, up to 03 Aug 13, with 4 out-patients visits following. You will be paid £100 for each extra night required, and £60 for each out-patient visit. Travel payments are also provided.
If you are interested in participating, or would like to be kept informed about the trial when more information becomes available, please call Covance Clinical Research on 0113 3945200 or 0800 591570.
[Please note: This is a promotional post on behalf of Covance Inc Clinical Research]